Clinical Trial Update: Platelet Rich Fibrin+1.2% Atorvastatin in Treatment of Mandibular Degree II Furcation Defects [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated Platelet Rich Fibrin with 1.2% atorvastatin for mandibular degree II furcation defects; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Furcation Defects | Phase 2, Phase 3 | Status: COMPLETED